Gene · 4299
Papers2,225
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,225
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Noncoding rules of survival: epigenetic regulation of normal and malignant hematopoiesis. | Front Mol Biosci | 2023 | 38028538 | PubTator, text mining | PubMed |
| Extracellular vesicle small RNA cargo discriminates non-cancer donors from pediatric B-lymphoblastic leukemia patients. | Front Oncol | 2023 | 38023151 | PubTator, text mining | PubMed |
| A Review of Childhood Acute Myeloid Leukemia: Diagnosis and Novel Treatment. | Pharmaceuticals (Basel) | 2023 | 38004478 | PubTator, text mining | PubMed |
| Prediction of folding patterns for intrinsic disordered protein. | Sci Rep | 2023 | 37990040 | PubTator, text mining | PubMed |
| Discovery, Structure-Activity Relationship and In Vitro Anticancer Activity of Small-Molecule Inhibitors of the Protein-Protein Interactions between AF9/ENL and AF4 or DOT1L. | Cancers (Basel) | 2023 | 37958457 | PubTator, text mining | PubMed |
| Bone marrow stromal cells reduce low-dose cytarabine-induced differentiation of acute myeloid leukemia. | Front Pharmacol | 2023 | 37954840 | PubTator, text mining | PubMed |
| Transcriptional co-activators: emerging roles in signaling pathways and potential therapeutic targets for diseases. | Signal Transduct Target Ther | 2023 | 37953273 | PubTator, text mining | PubMed |
| Congenital leukemia: A case report and review of literature. | World J Clin Cases | 2023 | 37946786 | PubTator, text mining | PubMed |
| Peptide-based approaches to directly target alpha-synuclein in Parkinson's disease. | Mol Neurodegener | 2023 | 37940962 | PubTator, text mining | PubMed |
| Exploration of the shared genetic biomarkers in Alzheimer's disease and chronic kidney disease using integrated bioinformatics analysis. | Medicine (Baltimore) | 2023 | 37933012 | PubTator, text mining | PubMed |
| Alterations in gut microbiota and host transcriptome of patients with coronary artery disease. | BMC Microbiol | 2023 | 37924005 | PubTator, text mining | PubMed |
| Interferon induced circRNAs escape herpesvirus host shutoff and suppress lytic infection. | bioRxiv | 2023 | 37886542 | PubTator, text mining | PubMed |
| Understanding blood development and leukemia using sequencing-based technologies and human cell systems. | Front Mol Biosci | 2023 | 37886034 | PubTator, text mining | PubMed |
| MAPK/ERK and PI3K/AKT signaling pathways are activated in adolescent and adult acute lymphoblastic leukemia. | Cancer Rep (Hoboken) | 2023 | 37867416 | PubTator, text mining | PubMed |
| Crosstalk between m6A modification and alternative splicing during cancer progression. | Clin Transl Med | 2023 | 37850412 | PubTator, text mining | PubMed |
| Outcomes of Second Anti-CD19 CAR T-Cell Therapy (CART2) in Acute B Lymphoblastic Leukemia and the Impact of Allo-HSCT on Efficacy. | Cell Transplant | 2023 | 37846503 | PubTator, text mining | PubMed |
| Uncovering NOTCH1 as a Promising Target in the Treatment of MLL-Rearranged Leukemia. | Int J Mol Sci | 2023 | 37833915 | PubTator, text mining | PubMed |
| Whole-exome sequencing reveals mutational profiles of anorectal and gynecological melanoma. | Med Oncol | 2023 | 37831226 | PubTator, text mining | PubMed |
| CSTF2 mediated mRNA N6-methyladenosine modification drives pancreatic ductal adenocarcinoma m6A subtypes. | Nat Commun | 2023 | 37816727 | PubTator, text mining | PubMed |
| Vascular multiple sclerosis: addressing the pathogenesis, genetics, pro-angiogenic factors, and vascular abnormalities, along with the role of vascular intervention. | Ann Med Surg (Lond) | 2023 | 37811110 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4299/papers?page=6